Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker

SUMMARY: Annual intravenous administration of zoledronic acid is used in the treatment of osteoporosis. A mathematical model was developed to predict bone mineral density up to 2 years after two annual doses of zoledronic acid from the early values of a bone resorption marker in osteoporosis patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Y., Kasai, H., Ose, A., Serada, M., Ishiguro, M., Shiraki, M., Tanigawara, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948273/
https://www.ncbi.nlm.nih.gov/pubmed/29423715
http://dx.doi.org/10.1007/s00198-018-4376-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948273/
https://www.ncbi.nlm.nih.gov/pubmed/29423715
http://dx.doi.org/10.1007/s00198-018-4376-1

Ejemplares similares